Pfizer lost its patent on the cholesterol-lowering drug Lipitor on November 30 -- which spells big savings for many of the 8.7 million Americans who take the medication. The patent’s expiration ...

Pharmaceutical giant Pfizer has agreed to pay $35 million to settle allegations that it unlawfully hindered the sale of Lipitor, a drug prescribed to lower cholesterol, resulting in buyers paying ...

Pfizer and Sun have denied any wrongdoing. Pfizer introduced Lipitor in 1997. The drug, used to treat high cholesterol, drove more than $130 billion in sales during its first 14 years on the market.